H E B Max Severe Congestion And Cough Liquid
NDC Package 37808-317-25
Package Information
H E B Max Severe Congestion And Cough (dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride) liquids is age - Adults and children 12 years and older Dose - 20 mL every 4 hoursAge - Children under 12 years of age Dose - Do not use take only as recommended use dosage cup mL = milliliter do not take more than 6 doses in any 24-hour period. This formulation utilizes a liquid delivery system. Marketed by H E B, this product is identified by NDC 37808-317 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1043543 - dextromethorphan HBr 5 MG / guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution
- RxCUI: 1043543 - dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
- RxCUI: 1043543 - dextromethorphan HBr 20 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution
- RxCUI: 1043543 - dextromethorphan HBr 5 MG / guaifenesin 100 MG / phenylephrine HCl 2.5 MG per 5 ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 37808 - H E B
- 37808-317 - H E B Max Severe Congestion And Cough
- 37808-317-25 - 177 mL in 1 BOTTLE
- 37808-317 - H E B Max Severe Congestion And Cough
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 37808-317-25 identifies a specific commercial package of 177 ml in 1 bottle of H E B Max Severe Congestion And Cough Maxium Strength, a human over the counter drug labeled by H E B. This liquid is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by H E B on September 14, 2012. The current certification is valid through December 31, 2026.
How is this H E B product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 37808031725. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.